Biotech Acquisition Co (Biotech Acquisition Co) Price-to-Tangible-Book : 1.34 (As of May. 23, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Biotech Acquisition Co Price-to-Tangible-Book?

As of today (2024-05-23), Biotech Acquisition Co's share price is $10.15. Biotech Acquisition Co's Tangible Book per Share of Sep. 2022 for the quarter that ended in Sep. 2022 was $7.59. Hence, Biotech Acquisition Co's Price to Tangible Book Ratio of today is 1.34.

The historical rank and industry rank for Biotech Acquisition Co's Price-to-Tangible-Book or its related term are showing as below:

BIOT's Price-to-Tangible-Book is not ranked ^*
in the Diversified Financial Services industry.
Industry Median: 1.86
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Biotech Acquisition Co's share price is $10.15. Biotech Acquisition Co's Book Value per Sharefor the quarter that ended in Sep. 2022 was $7.59. Hence, Biotech Acquisition Co's P/B Ratio of today is 1.34.

Biotech Acquisition Co Price-to-Tangible-Book Historical Data

The historical data trend for Biotech Acquisition Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotech Acquisition Co Price-to-Tangible-Book Chart

Biotech Acquisition Co Annual Data

Trend

Dec20

Dec21

Price-to-Tangible-Book

1.39

Biotech Acquisition Co Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Price-to-Tangible-Book	Get a 7-Day Free Trial				1.33	1.39	1.37	1.31	1.31

Competitive Comparison of Biotech Acquisition Co's Price-to-Tangible-Book

For the Shell Companies subindustry, Biotech Acquisition Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotech Acquisition Co's Price-to-Tangible-Book Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Biotech Acquisition Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Biotech Acquisition Co's Price-to-Tangible-Book falls into.

Biotech Acquisition Co Price-to-Tangible-Book Calculation

Biotech Acquisition Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Sep. 2022 )
	=	10.15	/	7.589
	=	1.34

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Biotech Acquisition Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Biotech Acquisition Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotech Acquisition Co (Biotech Acquisition Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Biotech Acquisition Co (NAS:BIOT) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

545 West 25th Street, 20th Floor, New York, NY, USA, 10001

Website

Biotech Acquisition Co is a blank check company.

Executives

Albert F Hummel	director, officer: Chief Investment Officer	PO BOX 3407, RANCHO SANTA FE CA 92067
Biotech Sponsor Llc	10 percent owner	545 W. 25TH ST., 20TH FLOOR, NEW YORK NY 10001
Bruno Montanari	director	545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001
Ivan Jarry	officer: Chief Operating Officer	545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001
Paul Bernard	director	545 WEST 25TH STREET 20TH FL, NEW YORK NY 10001
Aaron Kim	director	545 WEST 25TH STREET 20TH FL, NEW YORK NY 10001
Michael Schleifer	director, 10 percent owner, officer: Chief Executive Officer	545 WEST 25TH STREET 20TH FLOOR, NEW YORK NY 10001
Thomas Fratacci	officer: CFO & Treasurer	545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001